{"blog": [], "keywords": [{"value": "Prostate Cancer", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "Prostate Specific Antigen", "name": "subject", "rank": "2", "is_major": "N"}, {"value": "Tests (Medical)", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Surgery and Surgeons", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Radiation", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "New England Journal of Medicine", "name": "organizations", "rank": "6", "is_major": "Y"}, {"value": "Research", "name": "subject", "rank": "7", "is_major": "N"}, {"value": "Hamdy, Freddie C", "name": "persons", "rank": "8", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/09/15/health/prostate-cancer.html", "document_type": "article", "byline": {"person": [{"lastname": "GRADY", "firstname": "Denise", "role": "reported", "organization": "", "rank": 1}], "original": "By DENISE GRADY"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/09/15/science/15PROSTATE/15PROSTATE-thumbWide-v3.jpg", "legacy": {"wide": "images/2016/09/15/science/15PROSTATE/15PROSTATE-thumbWide-v3.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/09/15/science/15PROSTATE/15PROSTATE-articleLarge.jpg", "legacy": {"xlarge": "images/2016/09/15/science/15PROSTATE/15PROSTATE-articleLarge.jpg", "xlargeheight": "899", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 899}, {"url": "images/2016/09/15/science/15PROSTATE/15PROSTATE-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2016/09/15/science/15PROSTATE/15PROSTATE-thumbStandard-v2.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Health", "word_count": "1182", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "A 10-year study of more than 1,500 men with early prostate cancer found no difference in death rates between men who had surgery or radiation and those who monitored the disease.", "pub_date": "2016-09-15T04:00:00+0000", "news_desk": "Foreign", "headline": {"print_headline": "Prostate Study Details Value of Treatments", "main": "Prostate Cancer Study Details Value of Treatments"}, "print_page": "1", "snippet": "A 10-year study of more than 1,500 men with early prostate cancer found no difference in death rates between men who had surgery or radiation and those who monitored the disease....", "_id": "57d9bbb195d0e021d798643d", "slideshow_credits": null, "abstract": "Study published in The New England Journal of Medicine on early stages of prostate cancer finds that disease is more likely to advance and spread in those who choose so-called active monitoring instead of early treatment with surgery or radiation; study is first to include detailed information about side effects of different treatments provided by patients."}